<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/215998-pharmaceutical-moxifloxacin-preparation by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 10:09:58 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 215998:PHARMACEUTICAL MOXIFLOXACIN PREPARATION</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">PHARMACEUTICAL MOXIFLOXACIN PREPARATION</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The invention relates to a pharmaceutical preparation for oral administration, containing moxifloxacin, its salt and/or hydrate as well as lactose. The invention also relates to a method for producing said preparation and to its use for combating bacterial infections in man or animals.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>FORM 2<br>
THE PATENTS ACT 1970 [39 OF 1970]<br>
THE PATENTS RULES, 2003 COMPLETE SPECIFICATION [See Section 10; rule 13] "PHARMACEUTICAL MOXIFLOXACIN PREPARATION"<br>
BAYER HEALTHCARE AG, a body corporate organized under the laws of Germany of 51368 Leverkusen, Germany,<br>
The following specification particularly describes the invention and the manner in which it is to be performed:<br><br>
Le A 33 327 R/Kr/NT/09.11.1998<br>
Foreign Countries<br>
- 1 -<br><br>
Pharmaceutical preparation of moxifloxacin<br>
	The present invention relates to a pharmaceutical preparation for oral administration 	which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its <br>
5      preparation, and to the use of this preparation for controlling bacterial infections in 	humans or animals.<br>
Moxifloxacin (INN – International Nonproprietary Name) is an antibiotic having the following formula:<br><br>
10<br>
I-cycIopropyl-7-([S,S]-2,8-diazabicyclo[4.3;0]non-8-yI)-6-fluoro-l,4-dihydro-S-methoxy-4-oxo-3-quinolonecarboxylic acid<br>
15 	It is a highly effective antiinfective agent and was described for the first time in EP-A-0 350 733. EP-A-0 350 733 describes a pharmaceutical preparation which comprises the active compound, microcrystalline cellulose, maize starch, poly-(l-vinyI)-2-pyrroIidone (insoluble), finely divided silica and magnesium stearate.<br>
20 	Furthermore, EP-A-0 230 881 describes pharmaceutical preparations of ciprofloxacin, which is likewise an antibiotic from the class of the quinolonecarboxylic acids. The formulation of ciprofloxacin described in this publication corresponds to the formulation described in EP-A-350 733. However, if [his prior-art formulation is applied to moxifloxacin, it is unexpectedly found that<br>
25 	tablets manufactured using this formulation have a hardness or breaking load which in some cases, for example in the case of tablet formulations for blister packs, can be improved, and which also offers scope for improvements with respect to its release properties. It was therefore the object of the present application to provide a pharmaceutical formulation which can be used to prepare tablets having sufficient<br>
30 	hardness or breaking load, and which at the same time have excellent release properties.<br><br>
Le A 33 327<br>
-2-<br>
Surprisingly, we have found that the object described above can be achieved by a pharmaceutical formulation which comprises a certain amount of lactose.<br>
	The present invention accordingly provides pharmaceutical preparations for oral <br>
5 	administration which comprise moxifloxacin, at least one dry binder, at least one 	disintegrant and optionally a lubricant, characterized in that the preparation comprises 	from 2.5% to 25% of lactose (air percentages are % by weight based on the weight of 	the pharmaceutical preparations).<br>
10     Furthermore, the present invention provides a process for preparing tablets which comprise such preparations.<br>
The pharmaceutical preparation according to the invention is a preparation for oral administration.<br><br>
Salts of moxifloxacin include, for example, acid addition salts, such as salts of hydrochloric acid, sulphuric acid, acetic acid, lactic acid, etc., and also salts with bases, such as sodium hydroxide, potassium hydroxide, etc., and/or hydrates thereof,, such as, for example, the moxifloxacin hydrochloride, which is particularly preferred according to the invention, or a monohydrate thereof.<br>
	The formulation according to the invention preferably comprises from 50.to S5%, 	particularly preferably from 60 to 80%, of moxifloxacin or salts and/or hydrates 	thereof. <br>
25<br>
Based on the individual dose, the pharmaceutical preparation comprises generally from 50 to 800 mg of moxifloxacin, preferably from 100 to 600 mg, particularly preferably from 200 to 400 mg (in each case based on the betaine form).<br>
30 	Surprisingly, the use of lactose in the range of amounts according to the invention confers to the tablet which is prepared from the pharmaceutical preparation according to the invention an excellent hardness and breaking load, and simultaneously excellent release properties. A further advantage of the pharmaceutical preparation of the present invention consists in the-fact that it is accessible in a simple manner by<br>
35 	granulation, it being possible to use both micronized and non-micronized active compound, giving, in both cases, bioequivalent formulations.<br><br>
Le A 33 327<br>
-3-<br>
	The pharmaceutical preparation comprises, as components which are essential for 	achieving the object according to the invention, from 2.5 to 25% of lactose, 	preferably from 5 to 20% of lactose and particularly preferably from 7.5 to 16% of 	lactose. According to the invention, preference is given here to customary lactose <br>
5      monohydrate types.<br>
	The pharmaceutical preparation according to the invention comprises at least one dry 	binder, selected, for example, from the group consisting of: microcrystalline 	cellulose, fibre cellulose, calcium phosphates and mannitol. Particular preference <br>
10 	according to the invention is given to using microcrystalline cellulose. This is 	commercially available, for example under the name Avicel®. The pharmaceutical 	preparation advantageously comprises from 5 to 30%, preferably from 6.9 to 30%f 	particularly preferably from 12 to 25%, of the dry binder.<br>
15 	The pharmaceutical preparation according to the invention comprises at least one disintegrant, selected, for example, from the group consisting of starch, pregelatinized starch, starch glycolates, crosslinked polyvinylpyrrolidone and sodium carboxymethylcellulose (= croscarmellose sodium). Particular preference according to. the  invention  is  given  to  using croscarmellose  sodium. The  pharmaceutical<br>
20 	preparation advantageously comprises from 1 to 10%, preferably from 1.5 to 8%, particularly preferably from 2 to 6%, of the disintegrant.<br>
	The pharmaceutical preparation of the invention comprises at least one lubricant, 	selected from the group of the fatty acids and their salts. Particular preference <br>
25 	"according to the invention is given to using magnesium stearate. The lubricant is 	advantageously employed in an amount of from 0.3 to 2.0%, particularly preferably 	from 0.4 to 1.5% and most preferably from 0.5 to 1.1%.<br>
A particularly preferred pharmaceutical preparation of the invention comprises: <br>
30<br>
from 60 to 70% of moxifloxacin or salts and/or hydrates thereof,<br>
from 7.5 to 16% of lactose,   .<br>
from 2 to 6% of croscarmellose sodium,<br>
from 0.5 to 1.1% of magnesium stearate and <br>
35      	up to 30% of microcrystalline cellulose.<br><br>
Le A 33 327<br>
-4-<br>
	The pharmaceutical preparation of the invention can advantageously be prepared by a 	process in which moxifloxacin, its salt and/or hydrate, at least one dry binder and 	lactose are granulated using water, the granules are subsequently mixed with at least 	one disintegrant and at least one lubricant and, if appropriate, tableted and coated. <br>
5<br>
For the granulation, processes according to the principle of high-speed mixer granulation are used. The granulation can be carried out using water, without addition of an adhesive.<br>
10 	The pharmaceutical preparation of the present invention is particularly preferably employed in the form of a tablet formulation which may optionally be coated (as already mentioned above, the percentages by weight in the present patent application are based on the total weight of the pharmaceutical preparation without the weight of the Optional coating). For coating, it is possible to use coating formulations which are<br>
15 	customary in pharmaceutical technology, such as, for example, those based on hydroxypropylmethylcellulose (HPMC) and/or polyethylene glycol of various molecular weights. Furthermore, the coating may comprise customary pigments, such as, for example, titanium dioxide or red iron oxide.<br>
20 	The pharmaceutical preparation according to the invention is preferably used for the treatment or the prevention of bacterial infections in humans or animals.<br><br>
U A 33 327<br>
-5-<br>
Examples<br>
Example 1<br>
5      Tablet comprising 50 mg of moxifloxacin as micronized active compound, active compound content approximately 66% (based on the uncoated tablet):<br>
moxifloxacin hydrochloride, micronized	54.6 mg<br>
microcrystalline cellulose	17.0 mg<br>
10      lactose	8.5 mg<br><br>
croscarmellose sodium	2.0 mg<br>
masnesium stearate	0.6 mg<br><br>
HPMC coating	3.2 mg<br>
15      Example 2<br>
Tablet comprising 50 mg of moxifloxacin as micronized active compound, active compound content approximately 80% (based on the uncoated tablet):<br>
20<br>
moxifloxacin hydrochloride, micronized	54.6 mg<br>
microcrystalline c&amp;Ilulose	7.1 mg<br>
lactose	3.55 mg<br>
croscarmellose sodium	2.7 mg<br>
magnesium stearate	0.4 mg<br>
25<br>
Example 3<br>
Tablet comprising 50 mg of moxifloxacin as micronized active compound, active compound content approximately 65% (based on the uncoated tablet):<br>
30<br><br>
35<br><br><br>
moxifloxacin hydrochloride,	micronized	54.6 mg<br>
microcrystalline cellulose		12.8 mg<br>
lactose		12.8,mg<br>
croscarmellose sodium		3.4 mg<br>
magnesium stearate		0.5 mg<br><br>
Le A 33 327<br><br>
-6-Example 4<br>
Tablet comprising 200 mg of moxifloxacin as micronized active compound:<br>
5      		moxifloxacin hydrochloride, micronized   218.4 mg	microcrystalline cellulose      	                    68.0 mg<br>
  lactose                                                         34.0 mg<br>
	croscarmellose sodium                                8.0 mg         	magnesium stearate                                     2.4 mg<br>
10     	HPMC coating                                            9.0 mg<br>
Example 5<br>
Tablet comprising 400 mg of moxifloxacin as micronized active compound: 15<br><br><br>
moxifloxacin hydrochloride, micronized	436.8 mg<br>
microcrystalline cellulose		136.0 mg<br>
lactose		68.0 mg<br>
croscarmellose sodium		16.0 mg<br>
magnesium stearate		4.8 mg<br>
HPMC coating Example 6		14.0 mg<br>
25     Tablet comprising 400 mg of moxifloxacin as non-micronized active compound:<br>
moxifloxacin hydrochloride,	436.8 mg<br>
microcrystalline cellulose	136.0 mg<br>
lactose	68.0 mg<br>
30      croscarmellose sodium	32.0 mg<br>
magnesium stearate	6.0 mg<br>
HPMC coating	21.0 mg<br>
Figure I shows the comparison of the breaking strength of tablets according to <br>
35      Example 6 and the formulation according to EP-A-0 350 733 (page 53).<br><br>
Le A 33 327<br>
-7-<br>
Figure 2 shows the comparison of the release of moxifloxacin HCI from tablets according to Example 6 and the formulation according to EP-A-0 350 733.<br>
The tablets were in each case' prepared on a laboratory scale using comparable <br>
5      granulation and tabletting conditions.<br>
	Figure 1 shows clearly the improved tablet hardness of the formulation according to 	the invention. Nevertheless, the active compound is released more quickly, as shown 	in Figure 2. <br>
10<br>
Figure 3 shows the comparison of the blood concentration curves of tablets according to Example 5 and 6.<br>
	If tablets according to Example 5 (micronized moxifloxacin HCI) are compared to 15 	tablets according to Example 6 (non-micronized moxifloxacin HCI) with respect to 	their bioequivalence, a further unexpected advantage of the formulation according to 	the invention becomes evident, which consists in the fact that, inspite of the distinctly 	different dimensions of the active compound particles, both formulations give 	identical blood concentrations over time. Thus, a micronization step in the <br>
20      	formulation of the invention is not necessary, resulting in cost advantages.<br><br>
Le A 33 327<br>
-8-Patent Claims<br>
1.	 Pharmaceutical preparation for oral administration which comprises<br>
5	moxifloxacin or a salt and/or hydrate thereof,<br>
at least one dry binder, at least one disintegrant, and at least one lubricant,<br>
characterized in that the preparation comprises from 2.5% to 25% of lactose. 10<br>
2.	Pharmaceutical preparation for oral administration according to Claim I,<br>
characterized in that the preparation comprises from 50 to. 800 mg of<br>
moxifloxacin or its salts and/or hydrates, based on an individual dosage.<br>
15      3.	Pharmaceutical preparation for oral administration according to Claim 1 or 2,<br>
characterized in that the dry binder is microcrystalline cellulose.<br>
4.	Pharmaceutical preparation for oral administration according to any of Claims<br>
1 to 3, characterized in that the disintegrant is croscarmellose sodium.<br>
20<br>
5.	Pharmaceutical preparation for oral administration according to any of Claims<br>
1 to 4, characterized in that the lubricant is magnesium stearate.<br>
6.	Pharmaceutical preparation for oral administration according to any of Claims<br>
25	1 to 5, characterized in that it comprises:<br>
	from 60 to 76% of moxifloxacin or a salt and/or hydrate thereof,<br>
	from 7.5 to 16% of lactose,<br>
	from 2 to 6% of croscarmellose sodium,<br>
	from 0.5 to 1.1% of magnesium stearate,<br>
30	and up to 30% of microcrystalline cellulose.<br>
7.	Tablet preparation for oral administration which comprises a core of the<br>
pharmaceutical preparation according to any of Claims 1 to 6 and a film<br>
coating.<br>
35<br>
 8        Pharmaceutical preparation for oral administration according to any of Claims 1 to 7, characterized in that it comprises moxifloxacin hydrochloride.<br><br>
9.	Pharmaceutical preparation for oral administration as claimed in any of claims 1 to 8, for controlling bacterial infections in humans or animals.<br>
10.	Process for preparing the pharmaceutical preparation for oral administration as claimed in any of claims 1 to 8, characterized in that 50 to 85% of moxifloxacin or salts and/or hydrate thereof, 2.5 to 25% of lactose, 5 to 30% of the dry binder, 1 to 10% of the disintegrant and 0.3 to 2.0% of the lubricant are granulated using water, the granules are subsequently mixed with at least one disintegrant and at least one lubricant and, if appropriate, tabletted and coated.<br>
Dated	this	6th  day of      June,	2005.<br><br><br><br>
(JAYANTA PAL)<br>
OF REMFRY AND SAGAR <br>
ATTORNEY FOR THE APPLICANTS<br>
9<br><br>
Le A 33 327<br>
- 10-<br>
Pharmaceutical preparation  of moxifloxacin<br>
Abstract<br>
5 	The present invention relates to a pharmaceutical preparation for oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the use of this preparation for controlling bacterial infections in humans and animals.<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtYWJzdHJhY3QuZG9j" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-abstract.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtYWJzdHJhY3QucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY2FuY2VsbGVkIHBhZ2VzKDMwLTctMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-cancelled pages(30-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY2xhaW1zKGFtZW5kZWQpLSgzMC03LTIwMDcpLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-claims(amended)-(30-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY2xhaW1zKGdyYW50ZWQpLSg1LTMtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-claims(granted)-(5-3-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY2xhaW1zLmRvYw==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-claims.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY2xhaW1zLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY29ycmVzcG9uZGVuY2UoMTMtNy0yMDA5KS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-correspondence(13-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY29ycmVzcG9uZGVuY2UoaXBvKS0oNC00LTIwMDkpLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-correspondence(ipo)-(4-4-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY29ycmVzcG9uZGVuY2Utb3RoZXJzLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-correspondence-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY29ycmVzcG9uZGVuY2UtcmVjZWl2ZWQtdmVyLTA2MDYwNS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-correspondence-received-ver-060605.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtY29ycmVzcG9uZGVuY2UtcmVjZWl2ZWQtdmVyLTA4MTEwNS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-correspondence-received-ver-081105.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZGVzY3JpcHRpb24gKGNvbXBsZXRlKS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZGVzY3JpcHRpb24oZ3JhbnRlZCktKDUtMy0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-description(granted)-(5-3-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZHJhd2luZyhhbWVuZGVkKS0oMzAtNy0yMDA3KS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-drawing(amended)-(30-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZHJhd2luZyhncmFudGVkKS0oNS0zLTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-drawing(granted)-(5-3-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZHJhd2luZ3MucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-drawings.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAxKDMwLTctMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 1(30-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAxKDYtNi0yMDA1KS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 1(6-6-2005).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAxMygzMS03LTIwMDcpLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 13(31-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAxNigxMy03LTIwMDcpLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 16(13-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAxOCgxMC0xMS0yMDA1KS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 18(10-11-2005).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAyKGdyYW50ZWQpLSg1LTMtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 2(granted)-(5-3-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAyKHRpdGxlIHBhZ2UpLSg2LTYtMjAwNSkucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 2(title page)-(6-6-2005).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAyKHRpdGxlIHBhZ2UpLShncmFudGVkKS0oNS0zLTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 2(title page)-(granted)-(5-3-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybSAzKDMwLTctMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form 3(30-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybS0xLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybS0xOC5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form-18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybS0yLmRvYw==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form-2.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybS0yLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybS0zLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtZm9ybS01LnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-form-5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtcGN0LXNlYXJjaCByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-pct-search report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtcGV0aXRpb24gdW5kZXIgcnVsZSAxMzcoMzEtNy0yMDA3KS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-petition under rule 137(31-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtcG93ZXIgb2YgYXV0aG9yaXR5KDEzLTctMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-power of authority(13-7-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtcG93ZXIgb2YgYXV0aG9yaXR5KDMwLTctMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-power of authority(30-7-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtcG93ZXIgb2YgYXV0aG9yaXR5KDYtNi0yMDA1KS5wZGY=" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-power of authority(6-6-2005).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NTYyLW11bW5wLTIwMDUtd28gaW50ZXJuYXRpb25hbCBwdWJsaWNhdGlvbiByZXBvcnQoNi02LTIwMDUpLnBkZg==" target="_blank" style="word-wrap:break-word;">562-mumnp-2005-wo international publication report(6-6-2005).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=YWJzdHJhY3QxLmpwZw==" target="_blank" style="word-wrap:break-word;">abstract1.jpg</a></p>
		<br>
		<div class="pull-left">
			<a href="215997-a-radio-communication-system-and-a-method-of-operating-the-same.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="215999-swabbable-needleless-low-reflux-injection-port-system.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>215998</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>562/MUMNP/2005</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>13/2008</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>28-Mar-2008</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>05-Mar-2008</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>06-Jun-2005</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>BAYER HEALTHCARE AG</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>51368 LEVERKUSEN, GERMANY</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>PATRICK BOSCCHE</td>
											<td>SCHLINGHOFENER STRASSE 36, D-51519 ODENTHAL, GERMANY</td>
										</tr>
										<tr>
											<td>2</td>
											<td>MAHLER, Hans, Friedrich</td>
											<td>Haferkamp 6 D-51061 Köln (DE).</td>
										</tr>
										<tr>
											<td>3</td>
											<td>WEISEMANN, Claus</td>
											<td>204 Kelly Ridge Drive Apex, NC 27502 (US).</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K 31/4709</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP1999/008230</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>1999-10-29</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>198 55758.2</td>
									<td>1998-11-10</td>
								    <td>Germany</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/215998-pharmaceutical-moxifloxacin-preparation by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 10:09:59 GMT -->
</html>
